GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Research & Development

RP Bio lnc (XKRX:314140) Research & Development : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. RP Bio lnc's Research & Development for the three months ended in Mar. 2024 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.


RP Bio lnc Research & Development Historical Data

The historical data trend for RP Bio lnc's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Research & Development Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Research & Development
27.45 36.49 - -

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

RP Bio lnc Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RP Bio lnc  (XKRX:314140) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


RP Bio lnc Research & Development Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines